Latest News about pharmaceuticals
Recent news which mentions pharmaceuticals
CVS is working with advisors on strategic review, sources say
September 30, 2024
From CNBC.com News
Major CVS shareholder plans activist push, will meet with management, sources say
September 29, 2024
From CNBC.com News
BioAge seeks nearly $200 million in initial public offering
September 27, 2024
From Business Journals
FDA approves Bristol Myers Squibb's schizophrenia drug, the first new type of treatment in decades
September 26, 2024
From CNBC.com News
Enanta Pharmaceuticals Reports Antiviral For Respiratory Syncytial Virus Reduces Virus Levels, Symptoms In Study
September 26, 2024
From Benzinga
Novo Nordisk's diabetes drug Ozempic may lower the risk of opioid overdoses, study says
September 25, 2024
From CNBC.com News
Eli Lilly Touts Results Of EU-Approved Dermatitis Treatment, Shows Sustained Disease Control For Up To Three Years
September 25, 2024
From Benzinga
From CNBC.com News
Commentary: Congress has just weeks to help children with rare diseases
September 20, 2024
From Business Journals
FTC sues drug middlemen for allegedly inflating insulin prices
September 20, 2024
From CNBC.com News
Abbott Laboratories' Attractive Valuation Ranks It Among Top Large-Cap MedTech Companies, Says Analyst
September 19, 2024
From Benzinga
Novartis not joining the 'frenzy' of weight loss drugs, CEO says
September 18, 2024
From CNBC.com News
Pfizer says its experimental drug for deadly condition that causes appetite and weight loss in cancer patients shows positive trial results
September 14, 2024
From CNBC.com News
Biotech raises $315 million in IPO, surpassing $250M target
September 13, 2024
From Business Journals
Why Analyst Says Rare Disease-Focused Inozyme Pharma Stock 'Could Be Worth A Look'
September 12, 2024
From Benzinga
Biotech upsizes target for pending IPO to $250M
September 12, 2024
From Business Journals
Digital health company Noom to offer compounded GLP-1 drug through new weight loss program
September 12, 2024
From CNBC.com News
Moderna to cut $1.1 billion in costs and launch 10 new products by 2027 as it charts post-Covid future
September 12, 2024
From CNBC.com News
Eli Lilly to invest $1.8 billion to expand manufacturing for weight loss, diabetes and Alzheimer's drugs
September 12, 2024
From CNBC.com News
AstraZeneca shares fall 5% on disappointing lung cancer drug trial results
September 10, 2024
From CNBC.com News
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.